Access cutting-edge follicular lymphoma treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Access follicular lymphoma specialists in Rochester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related follicular lymphoma treatment provided free
The purpose of this study is to determine how effective and safe the combination of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other treatments for their lymphoma. The names of the study drugs involved in this study are: * Rituximab (a type of monoclonal antibody therapy) * Epcoritamab (a T-cell bispecific antibody)
Sponsor: Reid Merryman, MD
Check if you qualify for this follicular lymphoma clinical trial in Rochester, NY
If you're searching for follicular lymphoma treatment options in Rochester, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced follicular lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.